David K. Herron

2.0k total citations
44 papers, 1.5k citations indexed

About

David K. Herron is a scholar working on Physiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, David K. Herron has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 13 papers in Molecular Biology and 10 papers in Organic Chemistry. Recurrent topics in David K. Herron's work include Adipose Tissue and Metabolism (9 papers), Asthma and respiratory diseases (8 papers) and Exercise and Physiological Responses (5 papers). David K. Herron is often cited by papers focused on Adipose Tissue and Metabolism (9 papers), Asthma and respiratory diseases (8 papers) and Exercise and Physiological Responses (5 papers). David K. Herron collaborates with scholars based in United States, Sweden and Spain. David K. Herron's co-authors include Jan Nedergaard, Barbara Cannon, Stefan Rehnmark, M. Nechad, J. Scott Sawyer, Douglas W. Beight, William T. McMillen, Jonathan M. Yingling, Lei Yan and Theodore Goodson and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

David K. Herron

43 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David K. Herron United States 21 660 644 212 186 178 44 1.5k
H. J. Hohorst Germany 21 575 0.9× 369 0.6× 133 0.6× 68 0.4× 46 0.3× 49 1.4k
Wayne C. Glasgow United States 26 899 1.4× 201 0.3× 155 0.7× 149 0.8× 113 0.6× 46 1.9k
Julius Leyton United States 30 765 1.2× 282 0.4× 436 2.1× 98 0.5× 179 1.0× 47 2.1k
Pascal Grondin France 14 1.4k 2.1× 294 0.5× 89 0.4× 236 1.3× 190 1.1× 16 2.1k
Gary V. Richieri United States 22 1.5k 2.2× 356 0.6× 319 1.5× 49 0.3× 157 0.9× 30 2.1k
Emily A. Hull-Ryde United States 14 1.1k 1.6× 365 0.6× 105 0.5× 76 0.4× 136 0.8× 27 1.6k
Thomas McDonagh United States 18 1.1k 1.7× 981 1.5× 380 1.8× 120 0.6× 693 3.9× 28 3.1k
Anders Wetterholm Sweden 23 660 1.0× 598 0.9× 310 1.5× 179 1.0× 113 0.6× 49 1.7k
Jardena Nordenberg Israel 24 1.0k 1.5× 219 0.3× 234 1.1× 98 0.5× 73 0.4× 75 1.6k
C.J. Bos Netherlands 23 1.2k 1.8× 257 0.4× 314 1.5× 75 0.4× 172 1.0× 57 2.1k

Countries citing papers authored by David K. Herron

Since Specialization
Citations

This map shows the geographic impact of David K. Herron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David K. Herron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David K. Herron more than expected).

Fields of papers citing papers by David K. Herron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David K. Herron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David K. Herron. The network helps show where David K. Herron may publish in the future.

Co-authorship network of co-authors of David K. Herron

This figure shows the co-authorship network connecting the top 25 collaborators of David K. Herron. A scholar is included among the top collaborators of David K. Herron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David K. Herron. David K. Herron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sawyer, J. Scott, Douglas W. Beight, Bryan D. Anderson, et al.. (2004). Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-β type I receptor kinase domain. Bioorganic & Medicinal Chemistry Letters. 14(13). 3581–3584. 141 indexed citations
2.
Herron, David K., et al.. (2000). ChemInform Abstract: 1,2‐Dibenzamidobenzene Inhibitors of Human Factor Xa.. ChemInform. 31(21). 1 indexed citations
3.
Jackson, William T., Larry L. Froelich, Robert J. Boyd, et al.. (1999). Pharmacologic Actions of the Second-Generation Leukotriene B4 Receptor Antagonist LY293111: In Vitro Studies. Journal of Pharmacology and Experimental Therapeutics. 288(1). 286–294. 49 indexed citations
4.
Eacho, Patrick I., Patricia Foxworthy, Jeffrey Lawrence, David K. Herron, & Daniel J. Noonan. (1996). Common Structural Requirements for Peroxisome Proliferation by Tetrazole and Carboxylic Acid‐Containing Compounds. Annals of the New York Academy of Sciences. 804(1). 387–402. 4 indexed citations
5.
Wyse, B. M., et al.. (1996). Induction of uncoupling protein in brown adipose tissue. Biochemical Pharmacology. 52(5). 693–701. 77 indexed citations
6.
Herron, David K., et al.. (1995). Visualization and comparison of molecular dynamics simulations of leukotriene C4, leukotriene D4, and leukotriene E4. Journal of Molecular Graphics. 13(6). 337–341. 1 indexed citations
7.
Herron, David K., et al.. (1995). Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotamides. Prostaglandins Leukotrienes and Essential Fatty Acids. 52(5). 309–319. 2 indexed citations
8.
Nedergaard, Jan, David K. Herron, Anders Jacobsson, Stefan Rehnmark, & Barbara Cannon. (1995). Norepinephrine as a morphogen?: its unique interaction with brown adipose tissue. The International Journal of Developmental Biology. 39(5). 827–837. 34 indexed citations
9.
Harper, Richard W., et al.. (1994). Leukotriene B4 (LTB4) Receptor Antagonists: A Series of (Hydroxyphenyl)pyrazoles. Journal of Medicinal Chemistry. 37(15). 2411–2420. 18 indexed citations
11.
Silbaugh, Steven A., Peter W. Stengel, Sandra L. Cockerham, et al.. (1992). Pulmonary actions of LY255283, a leukotriene B4 receptor antagonist. European Journal of Pharmacology. 223(1). 57–64. 17 indexed citations
12.
Marder, Philip, Richard M. Schultz, Stephen M. Spaethe, Michael J. Sofia, & David K. Herron. (1992). Flow cytometric evaluation of the effects of leukotriene B4 receptor antagonists (LY255283 and SC-41930) on calcium mobilization and integrin expression of activated human neutrophils. Prostaglandins Leukotrienes and Essential Fatty Acids. 46(4). 265–270. 16 indexed citations
13.
Harper, Richard W., et al.. (1992). Development of a series of phenyltetrazole leukotriene D4(LTD4) receptor antagonists. Journal of Medicinal Chemistry. 35(7). 1191–1200. 12 indexed citations
14.
Herron, David K., et al.. (1992). Leukotriene B4 receptor antagonists: the LY255283 series of hydroxyacetophenones. Journal of Medicinal Chemistry. 35(10). 1818–1828. 37 indexed citations
15.
Schultz, Richard M., Philip Marder, Stephen M. Spaethe, David K. Herron, & Michael J. Sofia. (1991). Effects of two leukotriene B4 (LTB4) receptor antagonists (LY255283 and SC-41930) on LTB4-induced human neutrophil adhesion and superoxide production. Prostaglandins Leukotrienes and Essential Fatty Acids. 43(4). 267–271. 10 indexed citations
16.
Herron, David K., Stefan Rehnmark, M. Nechad, et al.. (1990). Norepinephrine‐induced synthesis of the uncoupling protein thermogenin (UCP) and its mitochondrial targeting in brown adipocytes differentiated in culture. FEBS Letters. 268(1). 296–300. 39 indexed citations
17.
Rehnmark, Stefan, Ján Kopecký, Anders Jacobsson, et al.. (1989). Brown adipocytes differentiated in vitro can express the gene for the uncoupling protein thermogenin: Effects of hypothyroidism and norepinephrine. Experimental Cell Research. 182(1). 75–83. 69 indexed citations
18.
Eacho, Patrick I., Patricia Foxworthy, Robert D. Dillard, et al.. (1989). Induction of peroxisomal β-oxidation in the rat liver in vivo and in vitro by tetrazole-substituted acetophenones: Structure-activity relationships. Toxicology and Applied Pharmacology. 100(1). 177–184. 29 indexed citations
19.
Silbaugh, Steven A., et al.. (1987). Effects of Leukotriene B 4 Inhalation: Airway Sensitization and Lung Granulocyte Infiltration in the Guinea Pig. American Review of Respiratory Disease. 136(4). 930–934. 44 indexed citations
20.
Corey, E. J. & David K. Herron. (1971). A method for the stereospecific synthesis of trisubstituted olefins by 1,5-prototropic shift. Tetrahedron Letters. 12(20). 1641–1642. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026